The FDA is warning healthcare professionals and pharmacies to avoid using Hospira's unapproved potassium phosphates product in pediatric patients due to the potential for aluminum exposure up to 2x the FDA-recommended limits for PN. Read the pdf for the full FDA warning.
top of page
To test this feature, visit your live site.
Edited:Â Feb 10, 2023
Infants at Risk for Aluminum Toxicity with Unapproved Potassium Phosphates Drug Product
Infants at Risk for Aluminum Toxicity with Unapproved Potassium Phosphates Drug Product
0 comments
Like
Comments (0)
bottom of page